NYSE:CFX

Colfax Stock Forecast, Price & News

$43.48
+0.07 (+0.16 %)
(As of 04/12/2021 10:37 AM ET)
Add
Compare
Today's Range
$43.05
Now: $43.48
$43.89
50-Day Range
$40.44
MA: $45.65
$50.00
52-Week Range
$20.03
Now: $43.48
$50.26
Volume11,503 shs
Average Volume1.47 million shs
Market Capitalization$5.88 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.15
Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the infrastructure, wind power, marine/life sciences, pipelines, mobile/off-highway equipment, oil, gas, and mining markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and direct and independent distributors under the DJO brand. Colfax Corporation was founded in 1860 and is headquartered in Annapolis Junction, Maryland.
Colfax logo

Industry, Sector and Symbol

Industry Pumps & pumping equipment
Sub-IndustryIndustrial Machinery
CUSIP19401410
Phone301-323-9000
Employees15,400
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.33 billion
Cash Flow$5.21 per share
Book Value$29.63 per share

Profitability

Net Income$-527,650,000.00

Miscellaneous

Market Cap$5.88 billion
Next Earnings Date5/6/2021 (Estimated)
OptionableOptionable

Headlines

Barclays Downgrades Colfax (NYSE:CFX) to Underweight
April 6, 2021 |  americanbankingnews.com
CFX Mar 2021 30.000 call
March 23, 2021 |  ca.finance.yahoo.com
CFX Mar 2021 27.500 put
March 23, 2021 |  ca.finance.yahoo.com
Colfax (NYSE:CFX) Trading Down 5.1%
March 18, 2021 |  americanbankingnews.com
KeyCorp Boosts Colfax (NYSE:CFX) Price Target to $57.00
March 18, 2021 |  americanbankingnews.com
Colfax shares slips on - Seeking Alpha
March 17, 2021 |  seekingalpha.com
See More Headlines

MarketRank

Overall MarketRank

1.39 out of 5 stars

Industrial Products Sector

137th out of 396 stocks

Pumps & Pumping Equipment Industry

6th out of 8 stocks

Analyst Opinion: 1.2Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
$43.48
+0.07 (+0.16 %)
(As of 04/12/2021 10:37 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CFX News and Ratings via Email

Sign-up to receive the latest news and ratings for CFX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Colfax (NYSE:CFX) Frequently Asked Questions

Is Colfax a buy right now?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colfax in the last twelve months. There are currently 2 sell ratings, 3 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Colfax stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CFX, but not buy additional shares or sell existing shares.
View analyst ratings for Colfax
or view top-rated stocks.

What stocks does MarketBeat like better than Colfax?

Wall Street analysts have given Colfax a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Colfax wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Colfax's next earnings date?

Colfax is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021.
View our earnings forecast for Colfax
.

How were Colfax's earnings last quarter?

Colfax Co. (NYSE:CFX) issued its quarterly earnings data on Wednesday, February, 17th. The industrial products company reported $0.51 EPS for the quarter, beating analysts' consensus estimates of $0.50 by $0.01. The industrial products company had revenue of $828.12 million for the quarter, compared to analysts' expectations of $830.20 million. Colfax had a positive trailing twelve-month return on equity of 6.04% and a negative net margin of 0.24%.
View Colfax's earnings history
.

How has Colfax's stock price been impacted by Coronavirus (COVID-19)?

Colfax's stock was trading at $25.64 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CFX shares have increased by 69.6% and is now trading at $43.48.
View which stocks have been most impacted by COVID-19
.

What guidance has Colfax issued on next quarter's earnings?

Colfax updated its FY 2021 Pre-Market earnings guidance on Thursday, February, 18th. The company provided earnings per share (EPS) guidance of 2.00-2.15 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.02. The company issued revenue guidance of $3.531-3.624 billion, compared to the consensus revenue estimate of $3.39 billion.

What price target have analysts set for CFX?

13 analysts have issued 1-year price objectives for Colfax's stock. Their forecasts range from $6.50 to $57.00. On average, they anticipate Colfax's stock price to reach $40.19 in the next twelve months. This suggests that the stock has a possible downside of 7.6%.
View analysts' price targets for Colfax
or view top-rated stocks among Wall Street analysts.

Who are Colfax's key executives?

Colfax's management team includes the following people:
  • Mr. Mitchell P. Rales, Co-Founder & Chairman (Age 64, Pay $1)
  • Mr. Matthew L. Trerotola, Pres, CEO & Director (Age 54, Pay $2.98M)
  • Mr. Christopher M. Hix, Exec. VP of Fin. & CFO (Age 59, Pay $1.15M)
  • Mr. Daniel A. Pryor, Exec. VP of Strategy & Bus. Devel. (Age 53, Pay $1.13M)
  • Mr. Shyam Kambeyanda, Exec. VP and CEO & Pres of ESAB (Age 50, Pay $1.26M)
  • Mr. Brady R. Shirley, CEO of DJO & Exec. VP (Age 55, Pay $1.44M)
  • Mr. Steven L. Breitzka, Interim Sr. VP of Global Operations & Americas (Age 63)
  • Mr. Douglas J. Pitts, VP, Controller & Chief Accounting Officer (Age 62)
  • Mr. Terry Ross, VP of Investor Relations, Strategy & Bus. Devel.
  • Mr. Bradley J. Tandy, Sr. VP, Gen. Counsel & Sec. (Age 62)

What is Matthew Trerotola's approval rating as Colfax's CEO?

2 employees have rated Colfax CEO Matthew Trerotola on Glassdoor.com. Matthew Trerotola has an approval rating of 54% among Colfax's employees. This puts Matthew Trerotola in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Colfax's key competitors?

What other stocks do shareholders of Colfax own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Colfax investors own include Endologix (ELGX), (APA), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), AutoZone (AZO), The Charles Schwab (SCHW), Accenture (ACN), Honeywell International (HON), Micron Technology (MU) and Semtech (SMTC).

What is Colfax's stock symbol?

Colfax trades on the New York Stock Exchange (NYSE) under the ticker symbol "CFX."

Who are Colfax's major shareholders?

Colfax's stock is owned by many different retail and institutional investors. Top institutional investors include State of Alaska Department of Revenue (0.02%), Valeo Financial Advisors LLC (0.01%) and Carroll Financial Associates Inc. (0.00%). Company insiders that own Colfax stock include Brady Shirley, Christopher M Hix, Daniel A Pryor, Douglas J Pitts, Jason Maclean, Liam Kelly, Matthew L Trerotola, Patricia A Lang, Rajiv Vinnakota and Shyam Kambeyanda.
View institutional ownership trends for Colfax
.

Which major investors are selling Colfax stock?

CFX stock was sold by a variety of institutional investors in the last quarter, including Valeo Financial Advisors LLC. Company insiders that have sold Colfax company stock in the last year include Christopher M Hix, Jason Maclean, Matthew L Trerotola, Patricia A Lang, Rajiv Vinnakota, and Shyam Kambeyanda.
View insider buying and selling activity for Colfax
or view top insider-selling stocks.

Which major investors are buying Colfax stock?

CFX stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, and Carroll Financial Associates Inc.. Company insiders that have bought Colfax stock in the last two years include Brady Shirley, and Liam Kelly.
View insider buying and selling activity for Colfax
or or view top insider-buying stocks.

How do I buy shares of Colfax?

Shares of CFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Colfax's stock price today?

One share of CFX stock can currently be purchased for approximately $43.48.

How much money does Colfax make?

Colfax has a market capitalization of $5.88 billion and generates $3.33 billion in revenue each year. The industrial products company earns $-527,650,000.00 in net income (profit) each year or $2.33 on an earnings per share basis.

How many employees does Colfax have?

Colfax employs 15,400 workers across the globe.

What is Colfax's official website?

The official website for Colfax is www.colfaxcorp.com.

Where are Colfax's headquarters?

Colfax is headquartered at 420 NATIONAL BUSINESS PARKWAY 5TH FLOOR, ANNAPOLIS JUNCTION MD, 20701.

How can I contact Colfax?

Colfax's mailing address is 420 NATIONAL BUSINESS PARKWAY 5TH FLOOR, ANNAPOLIS JUNCTION MD, 20701. The industrial products company can be reached via phone at 301-323-9000.


This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.